Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.87
Delayed Data
As of Jun 19
 -0.12 / -4.01%
Today’s Change
2.58
Today|||52-Week Range
5.66
-0.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization270.0K277.0K284.0K289.0K
 
 
 
 
 
 
Operating ExpensesGross Income-270.0K-277.0K-284.0K-289.0K
 
 
 
 
 
General Expenses23.4M20.3M24.1M19.8M
 
 
 
 
 
Research And Development18.3M15.7M15.7M14.8M
 
 
 
 
 
Total Operating Expenses23.7M20.6M24.4M20.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.7M-20.6M-24.4M-20.1M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.8M
 
 
Interest Expense On Debt12.0K8.0K13.0K12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.6M-19.4M-23.2M-20.7M
 
 
 
 
 
Income Taxes-75.0K-100.0K0.00-65.0K
 
 
 
 
Net Income-22.5M-19.3M-23.2M-20.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS136.7M137.4M137.9M138.0M
 
 
 
 
 
Shares To Calculate EPS Diluted136.7M137.4M137.9M138.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.14-$0.17-$0.15
 
 
 
 
 
EPS Diluted-$0.16-$0.14-$0.17-$0.15